Trial · NCT05064397
Results by group370
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 370
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (AEs) | Eptinezumab | 106 | Participants | ||
| Conversion From Chronic Cluster Headache (cCH) to Episodic Cluster Headache (eCH): Number of Participants With No Cluster Headache (CH) Attacks for ≥3 Consecutive Months (≥12 Consecutive Weeks) | Eptinezumab | 7 | Participants | ||
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 1 | -3.63 | Standard Error 0.53 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 2 | -4.24 | Standard Error 0.70 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 3 | -4.90 | Standard Error 0.76 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 4 | -4.99 | Standard Error 0.94 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 13 | -7.22 | Standard Error 0.84 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 14 | -6.83 | Standard Error 0.85 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 15 | -6.06 | Standard Error 0.84 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 16 | -6.42 | Standard Error 0.96 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 25 | -6.18 | Standard Error 0.99 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 26 | -6.56 | Standard Error 0.86 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 27 | -7.56 | Standard Error 0.82 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 28 | -7.12 | Standard Error 0.83 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 37 | -6.55 | Standard Error 0.98 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 38 | -6.97 | Standard Error 0.84 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 39 | -6.71 | Standard Error 1.04 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times an Abortive Therapy (Oxygen and/or Triptans) Was Used | Eptinezumab | Week 40 | -7.09 | Standard Error 0.84 | Abortive therapy use per week |
| Change From Baseline in Weekly Number of Times An Abortive Therapy (Oxygen) Was Used | Eptinezumab | Week 1 | -1.72 | Standard Error 0.33 | Oxygen use per week |
| Change From Baseline in Weekly Number of Times An Abortive Therapy (Oxygen) Was Used | Eptinezumab | Week 2 | -2.43 | Standard Error 0.40 | Oxygen use per week |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05064397/results